Evidence map›Paper›PMID 28440784›Full record

ArticleDiagnostic and interventional radiology (Ankara, Turkey)

Dual-energy CT characteristics of colon and rectal cancer allows differentiation from stool by dual-source CT.

İlknur Özdeniz, İlkay S İdilman, Seyfettin Köklü, Erhan Hamaloğlu, Mustafa Özmen, Deniz Akata, Muşturay Karçaaltıncaba

Abstract read
In one paragraph

Article in Diagnostic and interventional radiology (Ankara, Turkey). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Dual-Energy CT in Oncologic Imaging.Tomography (Ann Arbor, Mich.) · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Dual-energy CT in colorectal cancers: beyond the density measurements.Diagnostic and interventional radiology (Ankara, Turkey)
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

İlknur ÖzdenizDepartment of Radiology, Hacettepe University School of Medicine, Ankara, Turkey. musturayk@yahoo.com.
İlkay S İdilman
Seyfettin Köklü
Erhan Hamaloğlu
Mustafa Özmen
Deniz Akata
Muşturay Karçaaltıncaba

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe aimed to determine dual-energy computed tomography (DECT) characteristics of colorectal cancer and investigate effectiveness of DECT method in differentiating tumor from stool in patients with colorectal cancer.

methodsFifty consecutive patients with colorectal tumors were enrolled. Staging was performed by DECT (80-140 kV) using dual-source CT after rectal air insufflation and without bowel preparation. Both visual and quantitative analyses were performed at 80 kV and 140 kV, on iodine map and virtual noncontrast (VNC) images.

resultsAll colorectal tumors had homogeneous pattern on iodine map. Stools demonstrated heterogeneous pattern in 86% (43/50) and homogeneous pattern in 14% (7/50) on iodine maps and were less visible on VNC images. Median density of tumors was 54 HU (18-100 HU) on iodine map and 28 HU (11-56 HU) on VNC images. Median density of stool was 36.5 HU (8-165 HU) on iodine map and -135.5 HU (-438 HU to -13 HU) on VNC images. The density of stools was significantly lower than tumors on both iodine map and VNC images (P < 0.001). The cutoff point of density measurement on VNC images was -1 HU with area under the curve of 1 and a sensitivity and specificity of 100%.

conclusionDensity or visual analysis of iodine map and VNC DECT images allow accurate differentiation of tumor from stool.

Indexed as

FecesAdultAgedAged, 80 and overColonColonography, Computed TomographicColorectal NeoplasmsDiagnosis, DifferentialFemaleHumansMaleMiddle AgedProspective StudiesRadiography, Dual-Energy Scanned ProjectionRectumReproducibility of Results

Identifiers

PMID28440784
PMCPMC5508947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.